FERRARA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 2.443
EU - Europa 1.796
AS - Asia 1.688
SA - Sud America 346
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 52
Totale 6.450
Nazione #
US - Stati Uniti d'America 2.374
SG - Singapore 761
UA - Ucraina 369
IE - Irlanda 302
SE - Svezia 285
BR - Brasile 279
RU - Federazione Russa 252
CN - Cina 244
VN - Vietnam 220
HK - Hong Kong 182
DE - Germania 119
IT - Italia 112
FR - Francia 109
FI - Finlandia 99
GB - Regno Unito 54
KR - Corea 51
CA - Canada 39
IN - India 37
JP - Giappone 29
BD - Bangladesh 24
IQ - Iraq 24
TR - Turchia 23
AR - Argentina 18
CH - Svizzera 18
AT - Austria 17
ID - Indonesia 17
MX - Messico 16
ZA - Sudafrica 16
UZ - Uzbekistan 15
EC - Ecuador 14
PK - Pakistan 14
CO - Colombia 12
MA - Marocco 12
MY - Malesia 10
BE - Belgio 9
NL - Olanda 9
PY - Paraguay 8
VE - Venezuela 8
KE - Kenya 7
PL - Polonia 7
SA - Arabia Saudita 7
ES - Italia 6
CZ - Repubblica Ceca 5
MD - Moldavia 5
GR - Grecia 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
LT - Lituania 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BI - Burundi 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LY - Libia 2
PE - Perù 2
SV - El Salvador 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 6.332
Città #
Singapore 506
Chandler 343
Dublin 302
San Jose 241
Hong Kong 181
Jacksonville 162
San Mateo 154
Boardman 118
Santa Clara 110
Ashburn 92
Moscow 88
Medford 86
Princeton 86
Dong Ket 81
Lauterbourg 76
Ann Arbor 73
Beijing 73
Des Moines 57
Wilmington 56
Seoul 51
Altamura 43
The Dalles 43
Ho Chi Minh City 42
Lawrence 41
New York 39
Perugia 38
Andover 37
Hanoi 33
Tokyo 29
Los Angeles 23
Piscataway 23
Norwalk 21
Saint Petersburg 21
São Paulo 20
Woodbridge 20
Munich 14
Edmonton 13
Baghdad 11
Falls Church 11
Izmir 11
Helsinki 10
Rio de Janeiro 10
Shanghai 10
Brussels 9
Haiphong 9
Chennai 8
Guayaquil 8
Tashkent 8
Dearborn 7
Nairobi 7
Phoenix 7
Ankara 6
Casablanca 6
Chicago 6
Da Nang 6
Dallas 6
Frankfurt am Main 6
Jakarta 6
Johannesburg 6
Lausanne 6
Nuremberg 6
San Paolo di Civitate 6
Stockholm 6
Toronto 6
Denver 5
Houston 5
Kuala Lumpur 5
Porto Alegre 5
San Francisco 5
Turku 5
Amsterdam 4
Asunción 4
Auburn Hills 4
Bengaluru 4
Brooklyn 4
Changsha 4
Chisinau 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Guangzhou 4
Guarulhos 4
Karachi 4
London 4
Montreal 4
Poplar 4
Três Lagoas 4
Vienna 4
Belo Horizonte 3
Bogotá 3
Boston 3
Bromma 3
Cambridge 3
Cape Town 3
Caracas 3
Coimbatore 3
Columbus 3
Duque de Caxias 3
Frankfurt Am Main 3
Ha Long 3
Totale 3.778
Nome #
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. 158
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 137
Basi genetiche della predisposizione alla tubercolosi (TB) ed alle micobatteriosi non tubercolari. 130
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? 124
Il trattamento della tubercolosi. 119
[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers] 113
Combination fluticasone end salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children 109
Cough mechanical assistance in neuromuscular patients with respiratory failure: a retrospective evaluation 106
A method to quantify mycobacteria infection of cells from in vitro experiments 106
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. 104
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 104
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test 103
Chronic empyema: importance of preventing complications in the management of pleural effusions 102
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. 102
Long term Moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. 100
Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension 99
Clinical and operational value of the XDR-TB definition. 96
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 94
Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. 91
Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. 91
Combination fluticasone and salmeterol vs fixed dose combination budesonide and formoterol in adults and children 89
Trends and challenges in tuberculosis in a medium-sized southern European setting 89
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 88
Sarcoidosi: patogenesi 85
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis. 84
Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. 82
Alveolar macrophages produce CCL18 during early phases infection by M. tuberculosis 82
C’è esigenza di interventi mirati nei lavoratori stranieri affettida infezione tubercolare latente? Uno studio sulla compliancealla terapia antitubercolare in operatori sanitari 81
Management of multidrug-resistant tuberculosis in Italy. 78
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy 78
Clinical use of levofloxacin in the long term treatment of drug resistant tuberculosis 78
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 77
Xpert MTB/RIF test for tuberculosis. 77
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 75
Mycobacterium tuberculosis induces CCL18 in human macrophages. 74
Corticosteroids for idiophatic pulmonary fibrosis. 73
Epidemiology and clinical managment of XDR-TB: a systematic review. 72
Dossier Tubercolosi. La tubercolosi agli inizi del XXI secolo: diagnosi e terapia 72
Macrolides for chronic asthma. 71
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. 71
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. 71
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis 70
Macrolides in the treatment of asthma and cystic fibrosis. 69
T-Cell Therapy: Options for Infectious Diseases 69
Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan 69
Tuberculosis in prisons: anatomy of global neglect. 68
Macrolides for chronic asthma. 67
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. 67
Il trattamento della Tubercolosi 66
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. 66
Micobatteriosi non tubercolari 65
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 65
The best on infections: update from the 2010 ERS Congress. 65
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy 65
Macrolides for chronic asthma 65
Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection. 64
Screening of immigrants in the UK for latent tuberculosis. 64
Differences among multidrug-resistant tuberculosis patients in two metropolitan areas 64
TB or not TB: update from the ERS Respiratory Infection Assembly 10. 64
High risk of tuberculosis in health care workers in Romania. 62
New tools for a better diagnosis of latent tuberculosis infection 62
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma 62
Blood tests for diagnosis of tuberculosis - Authors' reply. 61
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: The case of two Nordic countries 61
Validation of the tuberculin skin test cut-off in BCG vaccinated individuals using the QuantiFERON-TB Gold 60
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000. 60
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 59
Corticosteroids for IPF: a systematic review 57
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 56
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 54
I nuovi test per la diagnosi di infezione tubercolare. 53
Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome 53
Macrolides for chronic asthma. 52
Isoniazid preventive treatment: predictors of adverse events and treatment completion. 52
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test 51
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence 51
Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses? 50
High risk of tuberculosis in health care workers in Romania 49
No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses. 49
Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry 49
Extensively drug-resistant tuberculosis, Italy and Germany. 48
Need for combined interventions and operational research to tackle tuberculous meningitis 44
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group 43
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays 43
Tuberculosis: Novel opportunities to control an old disease. 41
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays 41
Totale 6.450
Categoria #
all - tutte 30.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022590 0 107 18 46 11 7 12 207 3 8 58 113
2022/20231.072 98 143 7 110 95 147 0 44 393 1 26 8
2023/2024362 21 57 22 10 4 3 59 3 68 5 53 57
2024/2025807 4 110 84 10 100 12 26 61 177 52 128 43
2025/20262.157 141 171 138 304 245 175 333 91 324 172 41 22
2026/202787 41 46 0 0 0 0 0 0 0 0 0 0
Totale 6.450